Advertisement
| astrazeneca medical education grants: Defining Excellence in Simulation Programs Janice C. Palaganas, Juli C. Maxworthy, Chad A. Epps, Mary E. Mancini, 2014-10-07 An Official Publication of the Society for Simulation in Healthcare, Defining Excellence in Simulation Programs aims to meet the needs of healthcare practitioners using simulation techniques for education, assessment, and research. Increasingly, simulation is an integral part of teaching and training programs in healthcare settings around the world. Simulation models, including virtual simulation, scenario-based simulation with actors, and computerized mannequins, contributes to improved performance and reduced errors in patient care. This text establishes working definitions and benchmarks for the field of simulation and defines the types of simulation programs, while also covering program leadership, funding, staffing, equipment and education models. It provides knowledge critical to the success of simulation program management, simulation educators, and simulation researchers. Written to appeal to the novice to advanced beginner, a special section in each chapter is directed to the competent to expert programs, managers, educators, and researchers, so that this text truly can serve as the comprehensive reference for anyone in simulation. |
| astrazeneca medical education grants: The Master Adaptive Learner William Cutrer, Martin Pusic, Larry D Gruppen, Maya M. Hammoud, Sally A. Santen, 2019-09-29 Tomorrow's best physicians will be those who continually learn, adjust, and innovate as new information and best practices evolve, reflecting adaptive expertise in response to practice challenges. As the first volume in the American Medical Association's MedEd Innovation Series, The Master Adaptive Learner is an instructor-focused guide covering models for how to train and teach future clinicians who need to develop these adaptive skills and utilize them throughout their careers. - Explains and clarifies the concept of a Master Adaptive Learner: a metacognitive approach to learning based on self-regulation that fosters the success and use of adaptive expertise in practice. - Contains both theoretical and practical material for instructors and administrators, including guidance on how to implement a Master Adaptive Learner approach in today's institutions. - Gives instructors the tools needed to empower students to become efficient and successful adaptive learners. - Helps medical faculty and instructors address gaps in physician training and prepare new doctors to practice effectively in 21st century healthcare systems. - One of the American Medical Association Change MedEd initiatives and innovations, written and edited by members of the ACE (Accelerating Change in Medical Education) Consortium – a unique, innovative collaborative that allows for the sharing and dissemination of groundbreaking ideas and projects. |
| astrazeneca medical education grants: Transparency Metrics Gary Fradin, 2013-03-26 This engaging, provocative book helps guide brokers and their clients through the medical decision making process. It can turn you from uninformed to well-informed and help you get better care, with fewer risks, at lower costs. Along the way, you'll probably also improve your health and develop a better working relationship with your doctor. |
| astrazeneca medical education grants: The Grants Register 2025 Palgrave Macmillan, |
| astrazeneca medical education grants: Essential Evidence-Based Psychopharmacology Dan Stein, Bernard Lerer, Stephen M. Stahl, 2012-07-05 This volume presents up-to-date, comprehensive and high quality reviews of the psychopharmacological evidence-base for each of the major psychiatric disorders, written by expert psychopharmacologists from around the world. Building on the success of the first edition, the volume summarizes the wealth of new developments in the field and sets them within the context of day-to-day clinical practice. All chapters have been fully updated and new contributions on personality disorders and substance dependence added. Each chapter provides information about optimal first line pharmacological interventions, maintenance pharmacotherapy and the management of treatment-refractory patients. The content is organized according to the DSM-V listing of psychiatric disorders, and covers all major conditions including schizophrenia, mood disorders, anxiety disorders, eating disorders and Alzheimer's disorder. These issues lie at the heart of clinical psychopharmacology, making this book invaluable to all practising and trainee clinicians, in a mental health setting or a less specialised environment. |
| astrazeneca medical education grants: Medical Illness and Schizophrenia Jonathan M. Meyer, Henry A. Nasrallah, 2009-04-27 Despite growing awareness in the psychiatric community of the multifaceted medical needs of the severely mentally ill, statistics show that as much as 60% of all schizophrenia patients die prematurely from nonpsychiatric medical conditions -- in part because many physicians have not yet recognized how to properly treat common diseases and illnesses within this complex patient population. Medical Illness and Schizophrenia, Second Edition, is the only clinical guide to focus exclusively on the treatment of common medical comorbidities among patients with schizophrenia. Like its best-selling predecessor, the book compiles the latest research and clinical information on integrating medical and psychiatric care for the schizophrenia patient. Twenty-eight physicians and psychiatrists, including editors Jonathan M. Meyer, M.D., and Henry A. Nasrallah, M.D., lend their expertise to this new, expanded edition. In fifteen chapters, this volume covers a wide range of common medical problems -- from metabolic and heart conditions, such as cardiovascular disease, hyperlipidemia, obesity and diabetes, to substance abuse and smoking. Each chapter concludes with Key Clinical Points that summarize important concepts and ensure reader retention. Additionally, the second edition includes new chapters that touch on some of the most complex clinical issues in the field of schizophrenia treatment today: Recent trends in the integration of medical and mental healthcare Behavioral treatments for weight loss in persons with schizophrenia Treatment of sexual dysfunction among persons treated for schizophrenia Health outcomes of schizophrenia treatment in children and adolescents Health outcomes of schizophrenia treatment during pregnancy and breastfeeding As the only clinical text of its kind, Medical Illness and Schizophrenia, Second Edition, is an invaluable resource for psychiatrists, nurses, healthcare professionals, and psychiatric and clinical residents. The goal of this text has always been to help clinicians recognize schizophrenia as both a brain disorder and a systemic disease with multiple manifestations that go beyond the obvious psychiatric symptoms -- and thus take a broader approach to treatment of schizophrenia. This new edition is a comprehensive, practical manual that serves as a reference for the medical management of seriously mentally ill patients across the age spectrum in both inpatient and outpatient settings. |
| astrazeneca medical education grants: Cognitive Behavioral Therapy, An Issue of Child and Adolescent Psychiatric Clinics of North America Todd Peters, Jennifer Freeman, 2011-04-28 This issue provides a unique and valuable perspective on forensic matters in child and adolescent psychiatry, with an approach that adds new thinking to the discussion, rather than rehashing known facts. The issue is divided into several sections: juvenile offenders, family law/custody and visitation, child maltreatment, personal injury law suits, forensic issues in clinical child and adolescent psychiatry, and training in child and adolescent psychiatry. A wide range of topics are explored within each section. All articles are geared toward child psychiatrists in clinical practice, providing practical information in this very important area of study. |
| astrazeneca medical education grants: The Grants Register 2023 Palgrave Macmillan, 2022-09-28 The Grants Register 2023 is the most authoritative and comprehensive guide available of postgraduate and professional funding worldwide. It contains international coverage of grants in almost 60 countries, both English and non-English speaking; information on subject areas, level of study, eligibility and value of awards; and information on over 6,000 awards provided by over 1,300 awarding bodies. Awarding bodies are arranged alphabetically with a full list of awards to allow for comprehensive reading. The Register contains full contact details including telephone, fax, email and websites as well as details of application procedures and closing dates. It is updated annually to ensure accurate information. |
| astrazeneca medical education grants: Treating Addiction as a Disease United States. Congress. House. Committee on Oversight and Government Reform. Subcommittee on Domestic Policy, 2011 |
| astrazeneca medical education grants: The Grants Register 2024 Palgrave Macmillan, 2023-09-23 The Grants Register 2024 is the most authoritative and comprehensive guide available of postgraduate and professional funding worldwide. It contains international coverage of grants in almost 60 countries, both English and non-English speaking; information on subject areas, level of study, eligibility and value of awards; and information on over 6,000 awards provided by over 1,300 awarding bodies. Awarding bodies are arranged alphabetically with a full list of awards to allow for comprehensive reading. The Register contains full contact details including telephone, fax, email and websites as well as details of application procedures and closing dates. It is updated annually to ensure accurate information. |
| astrazeneca medical education grants: DSM-5® Clinical Cases John W. Barnhill, 2013-11-08 DSM-5® Clinical Cases presents patient cases that exemplify the mental disorders categorized in the newly released DSM-5®, bringing DSM-5® alive for teachers and students of psychiatry, psychology, social work, nursing, and related mental health and healthcare fields. Cases are cross-referenced with DSM-5® and help the reader understand diagnostic concepts, including symptoms, severity, comorbidities, age of onset and development, dimensionality across disorders, and gender and cultural implications. Every feature in the book helps to bridge the distance between the formal classification and the real-life presentation of patients: All cases are original and previously unpublished, making for fresh, compelling reading for both experienced clinicians and those new to diagnostic classification. Case authors were selected for their expertise in the disorder described in the case. For ease in identifying specific cases, case titles are clinically relevant, based on the primary complaint, and identify the DSM-5® diagnosis described. Each case adheres to a consistent format developed by the editors to fully illuminate the disorder being profiled. Features may include history of present illness, family psychiatric history, medical history, mental status exam results, DSM-5® diagnostic features, lab and physical findings, and a summary. A brief discussion follows each case, analyzing the clinical presentation, highlighting key points, and exploring issues of comorbidity that may complicate both the diagnosis and subsequent treatment. This approach is especially helpful since few cases in real-life are unambiguous. Easy-to-use appendixes enable readers to locate cases by type of disorder, special interests, and DSM-5® diagnosis. The book is designed to serve as a companion text in a variety of contexts -- from abnormal psychology courses to medical school and residency training programs. In addition, those studying for specialty examinations will find reviewing the cases very useful. Fascinating, practical, and instructive, DSM-5® Clinical Cases succeeds in bringing the DSM-5® to the examining room. |
| astrazeneca medical education grants: Disaster Psychiatry Frederick J. Stoddard, Anand Pandya, Craig L. Katz, 2012-09-24 It is becoming increasingly common for psychiatrists to be among the first responders when disaster strikes. More than 800 psychiatrists are believed to have responded to the 9/11 attacks. The first clinical manual on the best practices for helping those affected by disaster, Disaster Psychiatry: Readiness, Evaluation, and Treatment offers an explicit and practical discussion of the evidence base for recommendations for psychiatric evaluation and interventions for disaster survivors. Disaster is defined by the World Health Organization as a severe disruption, ecological and psychosocial, that greatly exceeds a community's capacity to cope. This manual takes an all-hazards approach to disasters and has application to natural occurrences such as earthquakes and hurricanes; accidental technological events such as airplane crashes; and willful human acts such as terrorism. The field of disaster psychiatry is more important than ever, in response to disasters such as the Deepwater Horizon oil spill in the Gulf of Mexico and the 2010 earthquake in Haiti. Today, disaster psychiatry encompasses a wide spectrum of clinical interests, ranging from public health preparations and early psychological interventions to psychiatric consultation to surgical units and psychotherapeutic interventions to alleviate stress in children and families after school shootings, hurricanes, or civil conflict. Although disaster mental health is still a young field, research is gradually yielding methods for accurately identifying valid relationships among preexisting risk factors, postdisaster mental health problems, and effective interventions. With its practical approach to readiness, response, and intervention and its focus on evidence-based recommendations for psychiatric evaluation and interventions, Disaster Psychiatry: Readiness, Evaluation, and Treatment is an invaluable manual for educator and student alike. The manual draws on a variety of sources, including the peer-reviewed scientific literature, the clinical wisdom imparted by front-line psychiatrists and other mental health professionals, and the experiences of those who have organized disaster mental health services, including the American Psychiatric Association and Disaster Psychiatry Outreach. Each chapter provides clear and concise information and in-depth review, followed by helpful study questions and answers. This book has been developed to give professionals the knowledge they need to respond swiftly and appropriately when disaster strikes. |
| astrazeneca medical education grants: Transcranial Magnetic Stimulation in Clinical Psychiatry Mark S. George, Robert H. Belmaker, 2007-04-02 As understanding evolves about how different brain regions are involved in carrying out everyday tasks -- and in causing brain diseases when they go awry -- this book describes a new technology that allows physicians to focally stimulate the brain in awake adults through a non-invasive procedure. Transcranial Magnetic Stimulation in Clinical Psychiatry is an accessible and authoritative review of TMS, a procedure that is showing promise as a treatment in several disorders. Its authors explain how the procedure works, then the latest findings in a wide range of situations -- notably in depression, but also in other conditions ranging from migraine to stroke recovery. This concise overview of TMS offers practical guidance for psychiatrists and other clinicians using it as a therapy, or referring their patients to have this done, as well as updating the field for neuroscientists and neurologists. It begins with background on the physics and safety of TMS, a guide for administering the procedure, and a review of basic neurophysiological studies with TMS, showing how it can be used to measure connectivity and excitability of the cerebral cortex. The heart of book is then devoted to its clinical applications, organized by disorder: Epilepsy, movement disorders, and pain -- describes the use of TMS in inducing and inhibiting seizures and investigating their pathophysiology; in treating Parkinson's disease; and in relieving pain through motor cortex stimulation Major depression -- provides a critical review of research in the most-studied clinical application of TMS in psychiatry, where it is used as a therapeutic intervention and a neurophysiological probe Mania -- explores the effectiveness of TMS in light of its ECT-like properties through a trial of right TMS vs. sham TMS Anxiety disorders -- reports on investigations on the uses of TMS in treating obsessive-compulsive disorder and posttraumatic stress disorder Schizophrenia -- reviews studies utilizing single- or paired-pulse TMS to assess cortical inhibition and those that explore effects of extended trains of repetitive TMS in altering symptoms A further chapter on TMS in brain imaging shows how integrating imaging and TMS allows one to better place the TMS coil, better understand TMS effects on the brain, and improve understanding of how the brain mediates behavior. With a concluding overview of prospects for the future of repetitive TMS, this volume offers a definitive look at this cutting-edge research and provides critical guidance on how and when clinicians might use TMS in their practice. |
| astrazeneca medical education grants: Scholarships, Fellowships, and Loans , 2003 |
| astrazeneca medical education grants: MKSAP 14 American College of Physicians (2003- ), 2006 |
| astrazeneca medical education grants: Global Status Report on Noncommunicable Diseases 2014 World Health Organization, 2014 This global status report on prevention and control of NCDs (2014), is framed around the nine voluntary global targets. The report provides data on the current situation, identifying bottlenecks as well as opportunities and priority actions for attaining the targets. The 2010 baseline estimates on NCD mortality and risk factors are provided so that countries can report on progress, starting in 2015. In addition, the report also provides the latest available estimates on NCD mortality (2012) and risk factors, 2010-2012. All ministries of health need to set national NCD targets and lead the development and implementation of policies and interventions to attain them. There is no single pathway to attain NCD targets that fits all countries, as they are at different points in their progress in the prevention and control of NCDs and at different levels of socioeconomic development. However all countries can benefit from the comprehensive response to attaining the voluntary global targets presented in this report.--Publisher description. |
| astrazeneca medical education grants: Emerging Infectious Diseases , 2015-07 |
| astrazeneca medical education grants: National Directory of Corporate Giving Andrew N. Grabois, 2008-08 Corporations donate billions of dollars every year to help nonprofit organizations. This Directory provides the most current information available in print on over 4,100 corporate donors. You'll find background on the sponsoring company, including: plant, office, division, and subsidiary locations, names of corporate officers, financial data, and Forbes and Fortune ratings. Get the latest facts on America's leading corporate funders with the National Directory of Corporate Giving, new 11th edition. |
| astrazeneca medical education grants: Foundation Grants to Individuals , 2006 |
| astrazeneca medical education grants: The American Journal of Psychiatry , 2009 |
| astrazeneca medical education grants: Directory of Research Grants 2008 Schoolhouse Partners LLC, 2008-05 Volume 2 of 2 - With more than 5,100 listings of grants programs from 1,880 sponsors, the Directory of Research Grants is a comprehensive directory of grants available to researchers in every field of study. The directory has a broad focus, featuring grants for basic research, equipment acquisition, building construction/renovation, fellowships, and 23 other program types. Government grants include CFDA, NSF and NIH program numbers. Each record includes grant title, description, requirements, amount, application deadline, contact information (phone, fax and email), web address, sponsor name and address, and samples of awarded grants (when available). Printed in two volumes, each with extensive indexes - subject, program type and geographic to help you to identify the right program quickly. |
| astrazeneca medical education grants: Acute Heart Failure Alexandre Mebazaa, Mihai Gheorghiade, Faiez Zannad, Joseph E. Parrillo, 2009-12-24 For many years, there has been a great deal of work done on chronic congestive heart failure while acute heart failure has been considered a difficult to handle and hopeless syndrome. However, in recent years acute heart failure has become a growing area of study and this is the first book to cover extensively the diagnosis and management of this complex condition. The book reflects the considerable amounts of new data reported and many new concepts which have been proposed in the last 3-4 years looking at the epidemiology, diagnostic and treatment of acute heart failure. |
| astrazeneca medical education grants: Let the Sunshine in United States. Congress. Senate. Special Committee on Aging, 2013 |
| astrazeneca medical education grants: Handbook of Clinical Pancreatology | Second Edition Professor Benedict Deveraux, 2021-11-16 Welcome to the second edition of the Handbook of Clinical Pancreatology an educational resource from the Gastroenterological Society of Australia. The world has certainly changed since the launch of the first edition in 2016. What has not changed is the complexity of pancreatic anatomy and physiology and the challenges we confront in managing patients with pancreatic pathology be it benign or malignant. The Handbook of Clinical Pancreatology has evolved and this second edition is greatly enhanced. Each Australian author has now been partnered with an international expert. I welcome authors from Scotland, England, France, Germany, The Netherlands, India, Thailand, Taiwan, New Zealand, Canada and the United States. The input of these experts brings a great depth and international perspective to the Handbook of Clinical Pancreatology. The second edition has also been augmented by the addition of three new chapters: Diabetes of the Exocrine Pancreas, Cystic Fibrosis and the Pancreas, and Paediatric Clinical Pancreatology. The primary aim of the Handbook remains unchanged, however; that is to be an up-to-date succinct guide rather than a definitive textbook, a resource that can be referred to in the lecture hall, hospital ward or consulting room. The Handbook will be of value to medical students through to practicing clinicians. It continues to highlight the necessity for a multidisciplinary approach to the treatment of pancreatic disorders. I hope the Handbook of Clinical Pancreatology broadens your knowledge, answers your specific questions and inspires you to make clinical pancreatology a focus of your career in patient care. |
| astrazeneca medical education grants: Severe Eosinophilic Disorders: Mechanisms and Clinical Management Shigeharu Ueki, Praveen Akuthota, Josiane Sabbadini Neves, 2019-12-04 |
| astrazeneca medical education grants: Directory of Biomedical and Health Care Grants , 2005 |
| astrazeneca medical education grants: Foundation Grants to Individuals Foundation Center, 2003 |
| astrazeneca medical education grants: Dimensional Approaches in Diagnostic Classification John E. Helzer, Helena C. Kraemer, Robert F. Krueger, Hans-Ulrich Wittchen, Paul J. Sirovatka, Darrel A. Regier, 2009-02-20 Since its initial publication more than 50 years ago, the DSM has systematized the complex intellectual and clinical process of diagnosing mentally ill persons through the use of categories and classification. The manuals have provided a consistent diagnostic language for clinical work, research, and teaching; have established a common international taxonomic standard; and have provided psychiatrists with a means of communicating with patients and the public. With a new iteration of the DSM on the horizon, the APA has initiated a multiphase research review process designed to set the stage for the fifth revision, due to be published in 2013. This book brings together the most promising research presented at the conference The Future of Psychiatric Diagnosis: Refining the Research Agenda, which was convened by the APA, in collaboration with the World Health Organization and the U.S. National Institutes of Health. Conferees were challenged to go beyond the current categorical definitions set forth in DSM-III and DSM-IV and suggest ways of incorporating more quantitative, dimensional concepts into DSM-V. The resulting work: Addresses the challenge of creating dimensional measures that are compatible with existing categorical definitions and do not unduly disrupt clinical practice Applies a dimensional approach to a broad range of diagnoses, including substance dependence, major depressive episode, psychosis, anxiety disorders, developmental psychopathology, and personality disorders Facilitates the development of broadly agreed upon criteria that researchers worldwide can use in planning and conducting future research exploring the etiology and pathophysiology of mental disorders Identifies and encourages the empirical research necessary to allow informed decision making regarding deficiencies acknowledged in DSM-IV Promotes international collaboration with the objective of eliminating the remaining disparities between DSM-V and the International Classification of Diseases Mental and Behavioural Disorders Section, the next edition of which is due to be released in 2014. The book's painstaking scholarship and thoughtful conclusions should stimulate interest in finding new ways of combining categorical and dimensional approaches in psychiatric nosology. Clinicians and researchers in the United States and the international psychiatric community will discover, in these pages, the beginnings of a new, quantitative methodology that represents the next stage in the evolution of DSM. |
| astrazeneca medical education grants: Powering Social Enterprise with Profit and Purpose Scott Boyer, Jeremy Gudauskas, Mike Hamel, 2023-03-01 Trail-blazing social entrepreneurs are tackling the world’s most pressing problems that government, business, or charity have failed to solve. They are creating businesses with a primary mission of social change. Scott Boyer is one such social entrepreneur. This 28-year veteran of Big Pharma left a six-figure salary to start OWP Pharmaceuticals and the ROW Foundation. This commercial business and non-profit organization exist in a symbiotic relationship we call a tandem hybrid social enterprise. This model combines a multimillion dollar business with a foundation that’s on track to become the largest funder of projects serving people with epilepsy and associated psychiatric disorders in the world. The tandem hybrid incorporates the principles learned by Scott and others for building a truly unique social enterprise from the ground up; one that is: Driven by a compelling social mission Financed by commercial success Structured to retain control Scalable and sustainable for the long haul Powering Social Enterprises With Profit And Purpose offers a detailed blueprint that has proven commercially and philanthropically successful and that can be replicated in most business sectors. |
| astrazeneca medical education grants: Schizophrenia Bulletin , 2013 |
| astrazeneca medical education grants: Foundation Grants to Individuals Phyllis Edelson, 2009 |
| astrazeneca medical education grants: Report of the Treasurer for the Year Ended December 31, 2017 National Academy of Sciences, 2018-07-06 The income that supports the activities of the National Academy of Sciences (NAS) comes from two major sources: program revenue received from sponsors to pay for the myriad studies and other activities undertaken each year by the National Academies of Sciences, Engineering, and Medicine, and a much smaller sum that is obtained from our endowment under the endowment spending policies adopted by the Council. The goal of the endowment is to provide stable support for the Academy's programs and activities. To achieve this goal, the Council, acting on the recommendations of the Finance Committee, has historically authorized spending from the portfolio at a rate designed to maintain the purchasing power of the endowment over time. This Report of the Treasurer of the National Academy of Sciences presents the financial position and results of operations as well as a review of the endowment, trust, and other long-term investments portfolio activities of our Academy for the year ended December 31, 2017. While this book provides essential financial summary to key personnel, it also serves as a vital informative resource for various members of the public, private, and governmental sectors. |
| astrazeneca medical education grants: Committee Staff Report to the Chairman and Ranking Member , 2007 |
| astrazeneca medical education grants: Chronic Obstructive Pulmonary Disease, An Issue of Clinics in Chest Medicine Gerard Criner, Bartolome R. Celli, 2020-09-01 This issue of Clinics in Chest Medicine, guest-edited by Dr. Gerard Criner and Dr. Bartolome Celli, is focused on Chronic Obstructive Pulmonary Disease. Topics discussed in this issue include but are not limited to: COPD Pathogenesis; Epidemiology of COPD; Host, Gender, and Early Life Factors as Risks for COPD; Alpha One Antitrypsin Deficiency; Lung Function Testing; Assessing Symptom Burden; Chest Imaging in the Diagnosis and Assessment of the Patient with COPD; Biomarkers in the Diagnosis and Assessment of COPD; Asthma/COPD Overlap; Multimorbidity in the Patient with COPD; Definition Causes, Pathogenesis, and Consequences of Exacerbations; Treatment of Acute Exacerbations; Prevention of Exacerbations; Bronchodilators; Benefits and Risks of Inhaled Corticosteroids in COPD; Systemic Medications; Smoking Cessation/Vaccinations; Pulmonary Rehabilitation; Oxygen Therapy/Noninvasive Ventilation; and Interventional and Surgical Therapies for COPD. |
| astrazeneca medical education grants: Inequalities in Respiratory Health Ian P. Sinha, Alice Lee, Vittal Katikireddi, Jennifer K. Quint, 2023-03-01 Health inequalities have long been deeply engrained in society. If we are to address these inequalities, we need to reflect on what has driven them, and critically review the approaches that do and do not work. This Monograph brings together leading experts and up-and-coming researchers, in a collection of state-of-the-art articles, discussing the drivers and consequences of respiratory inequality. |
| astrazeneca medical education grants: American Journal of Respiratory and Critical Care Medicine , 2009 |
| astrazeneca medical education grants: Vegetarian Dietary Patterns in the Prevention and Treatment of Disease Hana Kahleova, David L. Katz, 2020-08-07 |
| astrazeneca medical education grants: Pediatric Inflammatory Bowel Disease Petar Mamula, Jonathan E. Markowitz, Robert N. Baldassano, 2012-12-14 Pediatric Inflammatory Bowel Disease, Second Edition provides an essential reference with an emphasis on the unique pediatric issues of IBD. Chapters focus on complications of IBD specific to children and adolescents. Treatment recommendations are based on the latest clinical research available. The textbook also presents sections dedicated to the aspects of participation in clinical research unique to children and adolescents and the complicated yet vital process of successfully transitioning a patient from a pediatric to adult specialist. Controversies in pediatric IBD care such as the off-label use of medications are also covered. The format incorporates multiple tables, graphs, and figures to improve readability and make for an efficient reference for clinicians to use. Thoroughly revised and updated from the first edition, the volumes includes new therapies that are currently being used or tested for treatment of IBD, important areas regarding incidence and prevalence, immunization and response to vaccine administration as well as advancements in our understanding of growth and development with particular to the use of growth hormone therapy. Other new areas covered include important topics of complementary and alternative medicine use in IBD, immunization, and liver disease in IBD. Pediatric Inflammatory Bowel Disease, Second Edition is a valuable resource for pediatric gastroenterologists as well as adult gastroenterologists. |
| astrazeneca medical education grants: The Grants Register 2016 Palgrave Macmillan Ltd, 2016-12-27 The most comprehensive guide on postgraduate grants and professional funding globally. For thirty-four years it has been the leading source for up-to-date information on the availability of, and eligibility for, postgraduate and professional awards. Each entry is verified by its awarding body and all information is updated annually. |
| astrazeneca medical education grants: Directory of Research Grants 2005 Greenwood-Heinemann Publishing, 2004 A treasure chest of information on more than 5,100 current programs from 1,880 sponsors. Find grants for basic research, equipment acquisition, building construction/renovation, fellowships, and 23 other program types. |
AstraZeneca | Cafepharma Message Boards | Pharma Sales, Device …
May 15, 2025 · AstraZeneca. Anonymous board for AstraZeneca. Post thread AstraZeneca news. Click for latest AstraZeneca ...
Merck's Keytruda wins breakthrough head and neck
Merck (NYSE:MRK) got U.S. Patent Office support in its ongoing legal proceedings with Halozyme Therapeutics (NASDAQ:HALO) related to the lawsuit against the injectable version …
AstraZeneca
Anonymous board for AstraZeneca. AstraZeneca. Mike Hartman's son has a job at AZ, said restructuring in ...
Cafepharma | Pharmaceutical Sales, Medical Sales, Lab Sales
3 days ago · Cafepharma is a site for the pharmaceutical/medical industry. Our scope includes pharmaceutical, device, biotech, laboratory, animal health, dental, etc. We have curated daily …
Pfizer | Cafepharma Message Boards | Pharma Sales, Device Sales, …
Feb 23, 2025 · click for the latest Pfizer news items. 1; 2; 3 … Go to page
Pharma/Biotech Companies | Cafepharma Message Boards
Jul 19, 2015 · Anonymous discussion boards for pharmaceutical and biotech companies
GlaxoSmithKline | Cafepharma Message Boards | Pharma Sales, …
May 5, 2025 · Anonymous board for GlaxoSmithKline. Dovato reps being offered a package or becoming a Syneos Dovato rep prior to Q3
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Anonymous discussion boards for pharmaceutical sales, medical/device sales, lab/diagnostics sales
Cafepharma - News Headline Archives
Amylin leads drug stocks lower Marketwatch 8/19/08. Byetta woes threaten wider diabetes drug class Guardian, UK 8/19/08. Merck Vioxx study was for marketing: researchers Reuters 8
Latest CP Job Ratings
AstraZeneca Pharmaceuticals - job rating. Biomarin - job rating. Bristol Myers Squibb - job rating ...
Astellas, US Independent Medical Education and
Jan 20, 2023 · Eligible applicants include h ospitals, academic medical centers and medical schools (Note: the CME Office must submit the request for accredited activities ); national …
Inspiring the Next Generation of Young Leaders - AstraZeneca
Executive Vice President, Oncology R&D, AstraZeneca ” At AstraZeneca, we believe that access to science, technology, engineering and mathematics (STEM) education supports scientific …
Reporting of Transfers of Value to HCPs and HCOs …
2.2.1. Donations and Grants AZ provides support for medical or scientific education, advances in medical or scientific research, health or healthcare systems or disaster relief through financial …
Astrazeneca Medical Education Grants (Download Only)
The Grants Register 2025 Palgrave Macmillan, Best Evidence Medical Education R. M. Harden,1999 Medical Illness and Schizophrenia Jonathan M. Meyer,Henry A. Nasrallah,2009 …
Pharmaceutical Industry Fellowship Program 2025-2026
About AstraZeneca 1 Fellowship Campus Locations 2 A Message from our Executive Sponsors 3 A Message from our Fellowship Leadership Team 4 ... health outcomes, and medical …
AACR-AstraZeneca Stimulating Therapeutic Advances …
o Applicants with a medical degree must have completed their most recent doctoral degree or medical residency - whichever date is later - within the past three years. • Work under the …
“Step Up!” AstraZeneca Young Health Global Grants …
The AstraZeneca Young Health Global Grants Programme aims to extend the reach and impact of AstraZeneca’s investment in young people’s health. ... medical services. Pollution and air …
Pharmaceutical Industry Fellowship Program 2025-2026
About AstraZeneca 1 Fellowship Campus Locations 2 A Message from our Executive Sponsors 3 A Message from our Fellowship Leadership Team 4 ... health outcomes, and medical …
Reporting of Transfers of Value to HCPs, HCOs, and POs
2.2.1. Donations and Grants AZ provides support for medical or scientific education, advances in medical or scientific research, health or healthcare systems or disaster relief through financial …
ASTRO 2023 Annual Meeting Committee Disclosure of …
Christine Chung John Muir Medical Center: Radiation Oncologist: Employee None None None Eileen Connolly Columbia University Medical Center: Assistant Professor: Employee: Sites …
PROGRAM GUIDE
AstraZeneca Professional Education Grants AbbVie, Inc., through an independent educational grant Amgen AstraZeneca Daiicho Sanko, Inc. Exelixis Gilead Sciences, Inc. Incyte …
Reporting of Transfers of Value to HCPs and HCOs
2.2.1. Donations and Grants AZ provides support for medical or scientific education, advances in medical or scientific research, health or healthcare systems or disaster relief through financial …
Grants Finder Resource - TN.gov
nonprofits in grants; 6,849 grants awarded to 2,061 district nonprofits. In 2024, 28 different scholarship funds held at the Community Foundation made 140 scholarship awards to 137 …
Reporting of Transfers of Value to HCPs and HCOs
AstraZeneca AB 556011-7482 151 85 Södertälje Reporting of Transfers of Value to HCPs ... donations or Grants to Medical or Scientific Research. 2.2.2. Sponsorship Agreements ...
Standards & Guidance for External Education: Best Practices …
Senior Director, Medical Education Grants Office. AstraZeneca. John Ruggiero, BA, MPA, PhD. Head, Medical Affairs, Education & Health Services. Daiichi Sankyo, Inc. ... • Medical …
A N GDMT: A GDMT CKD? - KDIGO
• Speaker honoraria: AstraZeneca, Boehringer & Ingelheim, Cornerstone Medical Education, The Limbic, Medscape, American Diabetes Association, Renal Society of Australasia • …
SATELLITE SYMPOSIA AND EXHIBITOR GUIDE
PeerView Institute for Medical Education. This activity is supported through independent educational grants from AstraZeneca, Bristol-Myers Squibb, Genentech, and Merck & Co., Inc. …
Quality of Care Initiative to Improve the Treatment of ... - Pfizer
Apr 14, 2022 · Darmstadt, Germany in the United States and Canada) US Medical Education are collaborating to provide grant support in the area of mmunoi -oncology and in particular …
AstraZeneca Call For Grant Applications CGA Respiratory …
rhinologists may benefit from access to independent medical education on the role of epithelial cytokines in the pathophysiology and symptomatology of epithelial-driven inflammatory airway …
NCCN Continuing Education
Jun 10, 2024 · This activity is supported by educational grants from AstraZeneca; Exact Sciences; Novartis; and Taiho Oncology, Inc. This activity is supported byan in-dependent educational …
Reporting of Transfers of Value to HCPs and HCOs
AstraZeneca AB 556011-7482 151 85 Södertälje Reporting of Transfers of Value ... - Donations or Grants to Medical or Scientific Research. 2.2.2. Sponsorship Agreements ... established …
2024 Finland Alexion EFPIA Methodology Note_ENG
Title: Microsoft Word - 2024 Finland Alexion EFPIA Methodology Note_ENG Author: Bogiel, Anna Created Date: 6/12/2025 9:58:50 AM
FINLAND AZ EFPIA Methodological Note 2024 …
3djh 6frsh ri glvforvxuh 3urgxfwv frqfhuqhg $= lv d vflhqfh irfxvhg frpsdq\ ghyhorslqj lqqrydwlyh phglflqhv wkdw duh suhvfulswlrq
AstraZeneca Call For Grant Applications CGA Respiratory …
AstraZeneca – Call For Grant Applications CGA Respiratory AAAAI 2025_Epithelial Cytokines in Chronic Rhinosinusitis with Nasal Polyps Submission Deadline Accepting applications until 9 …
NCCN Continuing Education
Nov 10, 2024 · This activity is supported by educational grants from AstraZeneca; Exact Sciences; Novartis; and Taiho Oncology, Inc. This activity is supported by an independent educational …
Online Search Engines for Grant Funding (none specific to …
Training (CESERT) grant offered by the Association for Surgical Education Foundation. These grants aim to distribute funds that support groundbreaking research and education projects …
NING This activity is supported by educational grants from …
Dec 2, 2024 · GROUP This activity is supported by educational grants from AstraZeneca and Daiichi Sankyo, Inc. ... Chief Medical Officer, Lombardi Comprehensive Cancer Center . …
Grants Finder Resource - TN.gov
nonprofits in grants; 6,849 grants awarded to 2,061 district nonprofits. In 2024, 28 different scholarship funds held at the Community Foundation made 140 scholarship awards to 137 …
NCCN Continuing Education - jnccn.org
This activity is supported by educational grants from AstraZeneca; Exact Sciences; Novartis; and Taiho Oncology, Inc. This activity is supported byan in-dependent educational grant from …
NCCN Continuing Education - eScholarship
Aug 10, 2024 · This activity is supported by educational grants from AstraZeneca; Exact Sciences; Novartis; and Taiho Oncology, Inc. This activity is supported byan in-dependent educational …
Funding Opportunities April 2025 - nursing.jhu.edu
Pfizer Global Medical Grants & Partnerships (GMGP) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement, or education) to improve patient …
List of scholarships and grants - Lu
Page 1 of 76 Finance Endowment administration Emma Haverlind, administrator Postal address Box 117, 221 00 Visiting address Sandgatan 5 Telephone +46 222 71 44, +46 46 222 00 00 E …
CONTINUING MEDICAL EDUCATION - Journal of the …
continuing medical education work related to psoriasis. Dr Mehta is a full-time employee of the US Government. Dr Ogdie receives research grants from AbbVie (to the Group for Research and …
NCCN Continuing Education
Dec 10, 2024 · This activity is supported by educational grants from AstraZeneca; Exact Sciences; Novartis; and Taiho Oncology, Inc. This activity is supported byan in-dependent educational …
AMIA 2020 Virtual Annual Symposium - American Medical …
Nov 20, 2020 · The American Medical Informatics Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education …
LUXEMBOURG_AZ EFPIA Methodological Note_2024 …
3djh ghyldwlrqv zkhuh ehfdxvh ri pdqgdwru\ qdwlrqdo uhjxodwlrqv wkh frgh fdqqrw eh wudqvsrvhg lq ixoo 2qh glvforvxuh shu pdunhw lqfoxglqj doo 7r9v sdlg gluhfwo\ wkurxjk hqwlwlhv
Reporting of Transfers of Value to HCPs and HCOs
AstraZeneca AB 556011-7482 ... - Donations or Grants to Medical or Scientific Research. 2.2.2. Sponsorship Agreements AZ gives contributions, through financial or non-financial support to …
Reporting of Transfers of Value to HCPs and HCOs
AZ provides support without expecting any service in return for medical or scientific education, advances in medical or scientific research, health or healthcare systems or disaster relief …
NCCN Continuing Education
Aug 10, 2024 · This activity is supported by educational grants from AstraZeneca; Exact Sciences; Novartis; and Taiho Oncology, Inc. This activity is supported byan in-dependent educational …
Estonia_AZ EFPIA Methodological Note …
3djh 'rqdwlrqv dqg *udqwv $= surylghv vxssruw iru phglfdo ru vflhqwlilf hgxfdwlrq dgydqfhv lq phglfdo ru vflhqwlilf uhvhdufk khdowk ru khdowkfduh v\vwhpv ru glvdvwhu uholhi wkurxjk …
BELGIUM_AZ EFPIA Methodological …
3djh wkdw duh survshfwlyh lq qdwxuh duh frqvlghuhg 5hvhdufk 'hyhorsphqw 7r9v dqg duh uhsruwhg rq dq djjuhjdwh edvlv 5hwurvshfwlyh qrq lqwhuyhqwlrqdo vwxglhv ru rwkhu vwxglhv …
NCCN Continuing Education
Apr 10, 2024 · This activity is supported by educational grants from AstraZeneca; Exact Sciences; Novartis; and Taiho Oncology, Inc. This activity is supported byan in-dependent educational …
2024 Sweden Alexion EFPIA Methodology Note ENG
ü º t ã ¨ Ý 8 z 8 ³ ã ¬ @ n ã Ô º ! ã N u K ³ ü n Õ º Ñ ³0 n Ï Ï Ñ Ô Ñ ³ N ¬ ø Ý ü
Our Sustainability Impact - astrazeneca.com
that medical innovations can reach more people. We know that detecting and treating disease early improves health outcomes, relieves pressure on health systems and budgets, and …
NCCN Continuing Education
Mar 10, 2023 · education activity for 1.0 contact hour (0.1 CEUs) of con-tinuing education credit. UAN: JA4008196-0000-23-003-H01-P PAs: NCCN has been authorized by the American …
Satellite CME Symposium Harnessing the Potential of HER2 …
This activity is accredited by Medical Learning Institute, Inc. This activity is developed with our educational partner, PVI, PeerView Institute for Medical Education. This activity is supported …
party Educational Gifts Grants/ Donation Charitable Meetings ...
CC0085 Grants/ Educational Gifts 8 $471,072.00 Boston Scientific Corporation CC0087 Grants/ Educational Gifts 1 $5,000.00 Grifols CC0171 Education/ Training 2 $900.00 Novo Nordisk Inc. …
NCCN Continuing Education
Sep 10, 2024 · This activity is supported by educational grants from AstraZeneca; Exact Sciences; Novartis; and Taiho Oncology, Inc. This activity is supported byan in-dependent educational …
Acute Coronary Syndromes: Diagnosis and Management, …
Medicine, Brigham & Women’s Hospital and Harvard Medical School, Boston, MA (C.P .C.). Dr Cannon is a senior investigator for the Thrombolysis in Myocardial Infarction Study Group. He …
AstraZeneca Call For Grant Applications CGA Respiratory …
Accredited scientific/medical education that is being designed and implemented for US asthma specialists (allergist/immunologists and pulmonologists) and affiliated advance practice …
